1. A 3D pancreatic tumor model to study T cell infiltration
- Author
-
Yi Juan Teo, Hilaria Mollica, Andrea Pavesi, Giulia Adriani, Paolo Decuzzi, Damien Zhi Ming Tan, and Alrina Shin Min Tan
- Subjects
Tumor microenvironment ,Chemistry ,T-Lymphocytes ,T cell ,Pancreatic Stellate Cells ,Biomedical Engineering ,Endothelial Cells ,medicine.disease ,In vitro ,Pancreatic Neoplasms ,medicine.anatomical_structure ,Pancreatic tumor ,Pancreatic cancer ,Cancer cell ,Tumor Microenvironment ,medicine ,Hepatic stellate cell ,Cancer research ,Humans ,General Materials Science ,Infiltration (medical) ,Carcinoma, Pancreatic Ductal - Abstract
The desmoplastic nature of the pancreatic ductal adenocarcinoma (PDAC) tumor microenvironment (TME) prevents the infiltration of T cells and the penetration of chemotherapeutic drugs, posing a challenge to the validation of targeted therapies, including T cell immunotherapies. We present an in vitro 3D PDAC-TME model to observe and quantify T cell infiltration across the vasculature. In a three-channel microfluidic device, PDAC cells are cultured in a collagen matrix in the central channel surrounded, on one side, by endothelial cells (ECs) to mimic a blood vessel and, on the opposite side, by pancreatic stellate cells (PSCs) to simulate exocrine pancreas. The migration of T cells toward the tumor is quantified based on their activation state and TME composition. The presence of EC-lining drastically reduces T cell infiltration, confirming the essential role of the vasculature in controlling T cell trafficking. We show that activated T cells migrate ∼50% more than the not-activated ones toward the cancer cells. Correspondingly, in the absence of cancer cells, both activated and not-activated T cells present similar migration toward the PSCs. The proposed approach could help researchers in testing and optimizing immunotherapies for pancreatic cancer.
- Published
- 2021